Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (101-110 of 359) with videos related to

Pageof 36
Sort By:
Molecular Pharmaceutics|December 6, 2019
HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast CancerPatricia M R Pereira, Ashwin Ragupathi, Shayla Shmuel, et al.
Bioconjugate Chemistry|January 31, 2018
Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran PolymersJan-Philip Meyer, Kathryn M Tully, James Jackson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2006
64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumorsLihui Wei, Johnny Easmon, Ravneet K Nagi, et al.
Molecular Pharmaceutics|July 10, 2020
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian CancerKimberly Fung, Sai Kiran Sharma, Outi Keinänen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone)Farrokh Dehdashti, Perry W Grigsby, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervixJason S Lewis, Richard Laforest, Farrokh Dehdashti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelatorLihui Wei, Clayton Butcher, Yubin Miao, et al.
European Journal of Medicinal Chemistry|September 22, 2014
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expressionPierre Daumar, Brian M Zeglis, Nicholas Ramos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation DosesJacob L Houghton, Brian M Zeglis, Dalya Abdel-Atti, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary reportFarrokh Dehdashti, Perry W Grigsby, Mark A Mintun, et al.
Pageof 36

Showing results (101-110 of 359) with videos related to

Sort By:
Pageof 36
Molecular Pharmaceutics|December 6, 2019
HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast CancerPatricia M R Pereira, Ashwin Ragupathi, Shayla Shmuel, et al.
Bioconjugate Chemistry|January 31, 2018
Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran PolymersJan-Philip Meyer, Kathryn M Tully, James Jackson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2006
64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumorsLihui Wei, Johnny Easmon, Ravneet K Nagi, et al.
Molecular Pharmaceutics|July 10, 2020
A Molecularly Targeted Intraoperative Near-Infrared Fluorescence Imaging Agent for High-Grade Serous Ovarian CancerKimberly Fung, Sai Kiran Sharma, Outi Keinänen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2008
Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone)Farrokh Dehdashti, Perry W Grigsby, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervixJason S Lewis, Richard Laforest, Farrokh Dehdashti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelatorLihui Wei, Clayton Butcher, Yubin Miao, et al.
European Journal of Medicinal Chemistry|September 22, 2014
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expressionPierre Daumar, Brian M Zeglis, Nicholas Ramos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2015
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation DosesJacob L Houghton, Brian M Zeglis, Dalya Abdel-Atti, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2003
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary reportFarrokh Dehdashti, Perry W Grigsby, Mark A Mintun, et al.
Pageof 36